Skip to main content
SpringerLink
Log in

Surgical Management of Diabetic Macular Edema

  • Chapter
  • First Online:
Cystoid Macular Edema

Abstract

Diabetic macular edema (DME) is typically caused by leakage from abnormal retinal blood vessels. Mechanical causes at the vitreoretinal interface are increasingly implicated in select patients. Surgical interventions, including vitrectomy, epiretinal membrane (ERM) peel, and internal limiting membrane (ILM) peel, have been proposed in these patients to relieve traction, clear cytokines, and improve oxygenation. This chapter reviews the efficacy of these interventions, which varies by the type of vitreoretinal interface abnormality. Vitrectomy is beneficial in most DME cases where a taut posterior hyaloid or vitreomacular traction is present. It can also be beneficial in select cases where the posterior hyaloid is attached, even if there is no observable traction. When separation of the posterior hyaloid has occurred, vitrectomy can still be beneficial if an ERM is present. Unfortunately, favorable anatomic results, including improved thickness on optical coherence topography scans, are more common than improved visual results. This may reflect that surgical intervention is often performed for refractory DME cases with long-standing edema, with limited potential for substantial improvement. However, surgical intervention may be beneficial for select cases of DME, especially when surgical intervention is undertaken before photoreceptor damage has occurred.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Cogan DG, Toussaint D, Kuwabara T. Retinal vascular patterns. IV Diabetic retinopathy. Arch Ophthalmol. 1961;66:366–78.

    Article  CAS  PubMed  Google Scholar 

  2. O’Doherty M, Dooley I, Hickey-Dwyer M. Interventions for diabetic macular oedema: a systematic review of the literature. Br J Ophthalmol. 2008;92(12):1581–90.

    Article  PubMed  Google Scholar 

  3. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol. 1985;103(12):1796–806.

    Google Scholar 

  4. Kaiser PK, Riemann CD, Sears JE, Lewis H. Macular traction detachment and diabetic macular edema associated with posterior hyaloidal traction. Am J Ophthalmol. 2001;131(1):44–9.

    Article  CAS  PubMed  Google Scholar 

  5. Massin P, Duguid G, Erginay A, Haouchine B, Gaudric A. Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. Am J Ophthalmol. 2003;135(2):169–77.

    Article  PubMed  Google Scholar 

  6. Lewis H, Abrams GW, Blumenkranz MS, Campo RV. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology. 1992;99(5):753–9.

    Article  CAS  PubMed  Google Scholar 

  7. Pendergast SD, Hassan TS, Williams GA, Cox MS, Margherio RR, Ferrone PJ, et al. Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid. Am J Ophthalmol. 2000;130(2):178–86.

    Article  CAS  PubMed  Google Scholar 

  8. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329(14):977–86.

    Google Scholar 

  9. Yilmaz T, Weaver CD, Gallagher MJ, Cordero-Coma M, Cervantes-Castaneda RA, Klisovic D, et al. Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review. Ophthalmology. 2009;116(5):902–11; quiz 12–3.

    Article  PubMed  Google Scholar 

  10. Lam DS, Chan CK, Mohamed S, Lai TY, Lee VY, Liu DT, et al. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes. Ophthalmology. 2007;114(12):2162–7.

    Article  PubMed  Google Scholar 

  11. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology. 2002;109(5):920–7.

    Article  PubMed  Google Scholar 

  12. Nicholson BP, Schachat AP. A review of clinical trials of anti-VEGF agents for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2010;248(7):915–30.

    Article  CAS  PubMed  Google Scholar 

  13. Schubert HD. Cystoid macular edema: the apparent role of mechanical factors. Prog Clin Biol Res. 1989;312:277–91.

    CAS  PubMed  Google Scholar 

  14. Bringmann A, Wiedemann P. Involvement of Muller glial cells in epiretinal membrane formation. Graefes Arch Clin Exp Ophthalmol. 2009;247(7):865–83.

    Article  PubMed  Google Scholar 

  15. Wolfensberger TJ, Gregor ZJ. Macular edema–rationale for therapy. Dev Ophthalmol. 2010;47:49–58.

    Article  PubMed  Google Scholar 

  16. Smiddy WE, Green WR, Michels RG, de la Cruz Z. Ultrastructural studies of vitreomacular traction syndrome. Am J Ophthalmol. 1989;107(2):177–85.

    Article  CAS  PubMed  Google Scholar 

  17. Augustin A, Loewenstein A, Kuppermann BD. Macular edema. General pathophysiology. Dev Ophthalmol. 2010;47:10–26.

    Article  PubMed  Google Scholar 

  18. Lindqvist N, Liu Q, Zajadacz J, Franze K, Reichenbach A. Retinal glial (Muller) cells: sensing and responding to tissue stretch. Invest Ophthalmol Vis Sci. 2010;51(3):1683–90.

    Article  PubMed  Google Scholar 

  19. Noma H, Funatsu H, Mimura T, Harino S, Hori S. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Ophthalmology. 2009;116(1):87–93.

    Article  PubMed  Google Scholar 

  20. Praidou A, Klangas I, Papakonstantinou E, Androudi S, Georgiadis N, Karakiulakis G, et al. Vitreous and serum levels of platelet-derived growth factor and their correlation in patients with proliferative diabetic retinopathy. Curr Eye Res. 2009;34(2):152–61.

    Article  CAS  PubMed  Google Scholar 

  21. Praidou A, Papakonstantinou E, Androudi S, Georgiadis N, Karakiulakis G, Dimitrakos S. Vitreous and serum levels of vascular endothelial growth factor and platelet-derived growth factor and their correlation in patients with non-proliferative diabetic retinopathy and clinically significant macula oedema. Acta Ophthalmol. 2011;89(3):248–54.

    Article  CAS  PubMed  Google Scholar 

  22. Williamson TH, Grewal J, Gupta B, Mokete B, Lim M, Fry CH. Measurement of PO2 during vitrectomy for central retinal vein occlusion, a pilot study. Graefes Arch Clin Exp Ophthalmol. 2009;247(8):1019–23.

    Article  PubMed  Google Scholar 

  23. Stefansson E, Novack RL, Hatchell DL. Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci. 1990;31(2):284–9.

    CAS  PubMed  Google Scholar 

  24. Holekamp NM, Shui YB, Beebe DC. Vitrectomy surgery increases oxygen exposure to the lens: a possible mechanism for nuclear cataract formation. Am J Ophthalmol. 2005;139(2):302–10.

    Article  PubMed  Google Scholar 

  25. Siegfried CJ, Shui YB, Holekamp NM, Bai F, Beebe DC. Oxygen distribution in the human eye: relevance to the etiology of open-angle glaucoma after vitrectomy. Invest Ophthalmol Vis Sci. 2010;51(11):5731–8.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Giblin FJ, Quiram PA, Leverenz VR, Baker RM, Dang L, Trese MT. Enzyme-induced posterior vitreous detachment in the rat produces increased lens nuclear pO2 levels. Exp Eye Res. 2009;88(2):286–92.

    Article  CAS  PubMed  Google Scholar 

  27. Quiram PA, Leverenz VR, Baker RM, Dang L, Giblin FJ, Trese MT. Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels. Retina. 2007;27(8):1090–6.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Nasrallah FP, Jalkh AE, Van Coppenolle F, Kado M, Trempe CL, McMeel JW, et al. The role of the vitreous in diabetic macular edema. Ophthalmology. 1988;95(10):1335–9.

    Article  CAS  PubMed  Google Scholar 

  29. Hikichi T, Fujio N, Akiba J, Azuma Y, Takahashi M, Yoshida A. Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus. Ophthalmology. 1997;104(3):473–8.

    Article  CAS  PubMed  Google Scholar 

  30. Harbour JW, Smiddy WE, Flynn Jr HW, Rubsamen PE. Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol. 1996;121(4):405–13.

    Article  CAS  PubMed  Google Scholar 

  31. Gandorfer A, Messmer EM, Ulbig MW, Kampik A. Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina. 2000;20(2):126–33.

    Article  CAS  PubMed  Google Scholar 

  32. Krupin T, Waltman SR, Szewczyk P, Koloms B, Farber M, Silverstein B, et al. Fluorometric studies on the blood-retinal barrier in experimental animals. Arch Ophthalmol. 1982;100(4):631–4.

    Article  CAS  PubMed  Google Scholar 

  33. Kirber WM, Nichols CW, Grimes PA, Winegrad AI, Laties AM. A permeability defect of the retinal pigment epithelium. Occurrence in early streptozocin diabetes. Arch Ophthalmol. 1980;98(4):725–8.

    Article  CAS  PubMed  Google Scholar 

  34. Kim BY, Smith SD, Kaiser PK. Optical coherence tomographic patterns of diabetic macular edema. Am J Ophthalmol. 2006;142(3):405–12.

    Article  PubMed  Google Scholar 

  35. Baskin DE. Optical coherence tomography in diabetic macular edema. Curr Opin Ophthalmol. 2010;21(3):172–7.

    Article  PubMed  Google Scholar 

  36. Haller JA, Qin H, Apte RS, Beck RR, Bressler NM, Browning DJ, et al. Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology. 2010;117(6):1087–93. e3.

    Article  PubMed  Google Scholar 

  37. Ikeda T, Sato K, Katano T, Hayashi Y. Improved visual acuity following pars plana vitrectomy for diabetic cystoid macular edema and detached posterior hyaloid. Retina. 2000;20(2):220–2.

    Article  CAS  PubMed  Google Scholar 

  38. Otani T, Kishi S. Tomographic assessment of vitreous surgery for diabetic macular edema. Am J Ophthalmol. 2000;129(4):487–94.

    Article  CAS  PubMed  Google Scholar 

  39. La Heij EC, Hendrikse F, Kessels AG, Derhaag PJ. Vitrectomy results in diabetic macular oedema without evident vitreomacular traction. Graefes Arch Clin Exp Ophthalmol. 2001;239(4):264–70.

    Article  PubMed  Google Scholar 

  40. Yamamoto T, Akabane N, Takeuchi S. Vitrectomy for diabetic macular edema: the role of posterior vitreous detachment and epimacular membrane. Am J Ophthalmol. 2001;132(3):369–77.

    Article  CAS  PubMed  Google Scholar 

  41. Matsunaga N, Ozeki H, Hirabayashi Y, Shimada S, Ogura Y. Histopathologic evaluation of the internal limiting membrane surgically excised from eyes with diabetic maculopathy. Retina. 2005;25(3):311–6.

    Article  PubMed  Google Scholar 

  42. Saravia M. Persistent diffuse diabetic macular edema. The role of the internal limiting membrane as a selective membrane: the oncotic theory. Med Hypotheses. 2011;76(6):858–60.

    Article  CAS  PubMed  Google Scholar 

  43. Stefansson E. Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol. 2009;247(2):147–63.

    Article  PubMed  Google Scholar 

  44. Hoerauf H, Bruggemann A, Muecke M, Luke J, Muller M, Stefansson E, et al. Pars plana vitrectomy for diabetic macular edema. Internal limiting membrane delamination vs posterior hyaloid removal. A prospective randomized trial. Graefes Arch Clin Exp Ophthalmol. 2011;249(7):997–1008.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Gandorfer A, Rohleder M, Grosselfinger S, Haritoglou C, Ulbig M, Kampik A. Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction. Am J Ophthalmol. 2005;139(4):638–52.

    Article  PubMed  Google Scholar 

  46. Schaal S, Tezel TH, Kaplan HJ. Surgical intervention in refractory CME–role of posterior hyaloid separation and internal limiting membrane peeling. Ocul Immunol Inflamm. 2008;16(5):209–10.

    Article  PubMed  Google Scholar 

  47. Gentile RC, Milman T, Eliott D, Romero JM, McCormick SA. Taut internal limiting membrane causing diffuse diabetic macular edema after vitrectomy: clinicopathological correlation. Ophthalmologica. 2011;226(2):64–70.

    Article  PubMed  Google Scholar 

  48. Abe S, Yamamoto T, Kashiwagi Y, Kirii E, Goto S, Yamashita H. Three-dimensional imaging of the inner limiting membrane folding on the vitreomacular interface in diabetic macular edema. Jpn J Ophthalmol. 2013;57(6):553–62.

    Article  PubMed  Google Scholar 

  49. Kamura Y, Sato Y, Isomae T, Shimada H. Effects of internal limiting membrane peeling in vitrectomy on diabetic cystoid macular edema patients. Jpn J Ophthalmol. 2005;49(4):297–300.

    Article  PubMed  Google Scholar 

  50. Bahadir M, Ertan A, Mertoglu O. Visual acuity comparison of vitrectomy with and without internal limiting membrane removal in the treatment of diabetic macular edema. Int Ophthalmol. 2005;26(1–2):3–8.

    PubMed  Google Scholar 

  51. Rosenblatt BJ, Shah GK, Sharma S, Bakal J. Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid. Graefes Arch Clin Exp Ophthalmol. 2005;243(1):20–5.

    Article  PubMed  Google Scholar 

  52. Patel JI, Hykin PG, Schadt M, Luong V, Fitzke F, Gregor ZJ. Pars plana vitrectomy with and without peeling of the inner limiting membrane for diabetic macular edema. Retina. 2006;26(1):5–13.

    Article  PubMed  Google Scholar 

  53. Recchia FM, Ruby AJ, Carvalho Recchia CA. Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema. Am J Ophthalmol. 2005;139(3):447–54.

    Article  PubMed  Google Scholar 

  54. Yanyali A, Nohutcu AF, Horozoglu F, Celik E. Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema. Am J Ophthalmol. 2005;139(5):795–801.

    Article  PubMed  Google Scholar 

  55. Yanyali A, Horozoglu F, Celik E, Nohutcu AF. Long-term outcomes of pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema. Retina. 2007;27(5):557–66.

    Article  PubMed  Google Scholar 

  56. Maheshwary AS, Oster SF, Yuson RM, Cheng L, Mojana F, Freeman WR. The association between percent disruption of the photoreceptor inner segment-outer segment junction and visual acuity in diabetic macular edema. Am J Ophthalmol. 2010;150(1):63–7. e1.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Chhablani JK, Kim JS, Cheng L, Kozak I, Freeman W. External limiting membrane as a predictor of visual improvement in diabetic macular edema after pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol. 2012;250(10):1415–20.

    Article  PubMed  Google Scholar 

  58. Nishijima K, Murakami T, Hirashima T, Uji A, Akagi T, Horii T, et al. Hyperreflective foci in outer retina predictive of photoreceptor damage and poor vision after vitrectomy for diabetic macular edema. Retina. 2014;34(4):732–40.

    Article  PubMed  Google Scholar 

  59. Wakabayashi Y, Kimura K, Muramatsu D, Usui Y, Umazume K, Suzuki J, et al. Axial length as a factor associated with visual outcome after vitrectomy for diabetic macular edema. Invest Ophthalmol Vis Sci. 2013;54(10):6834–40.

    Article  PubMed  Google Scholar 

  60. Yamada Y, Suzuma K, Ryu M, Tsuiki E, Fujikawa A, Kitaoka T. Systemic factors influence the prognosis of diabetic macular edema after pars plana vitrectomy with internal limiting membrane peeling. Curr Eye Res. 2013;38(12):1261–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Massachusetts Eye & Ear Infirmary, Harvard Medical School, 243 Charles St., Boston, MA, 02114, USA

    Katherine E. Talcott MD

  2. Retina Service, Department of Ophthalmology, Massachusetts Eye & Ear Infirmary, Harvard Medical School, 243 Charles St., Boston, MA, 02114, USA

    Dean Eliott MD

Authors
  1. Katherine E. Talcott MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dean Eliott MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dean Eliott MD .

Editor information

Editors and Affiliations

  1. Professor and Chair Department of Ophthalmology and Visual Sciences, University of Massachusetts School of Medicine, Worcester, Massachusetts, USA

    Shlomit Schaal

  2. Evans Professor and Chair of Ophthalmology and Visual Sciences, University of Louisville, Louisville, Kentucky, USA

    Henry J. Kaplan

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Talcott, K.E., Eliott, D. (2017). Surgical Management of Diabetic Macular Edema. In: Schaal, S., Kaplan, H. (eds) Cystoid Macular Edema. Springer, Cham. https://doi.org/10.1007/978-3-319-39766-5_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-39766-5_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-39764-1

  • Online ISBN: 978-3-319-39766-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation